ffeng	10.2217/imt-2017-0059	<http://dx.doi.org/10.2217/imt-2017-0059>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.2217/imt-2017-0059"><j.2:pageStart>695</j.2:pageStart><owl:sameAs rdf:resource="doi:10.2217/imt-2017-0059"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/rohit-mehra-37wqyi2oky0ga"><j.3:name>Rohit Mehra</j.3:name><j.3:familyName>Mehra</j.3:familyName><j.3:givenName>Rohit</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/daniel-e-spratt-37wqyi2oky0ga"><j.3:name>Daniel E Spratt</j.3:name><j.3:familyName>Spratt</j.3:familyName><j.3:givenName>Daniel E</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.2217/imt-2017-0059</j.2:doi><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2017-08</j.0:date><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/michael-green-37wqyi2oky0ga"><j.3:name>Michael Green</j.3:name><j.3:familyName>Green</j.3:familyName><j.3:givenName>Michael</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>699</j.2:pageEnd><j.1:doi>10.2217/imt-2017-0059</j.1:doi><owl:sameAs rdf:resource="info:doi/10.2217/imt-2017-0059"/><j.1:startingPage>695</j.1:startingPage><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1750-743X"><owl:sameAs>urn:issn:1750-743X</owl:sameAs><j.1:issn>1750-7448</j.1:issn><j.2:issn>1750-7448</j.2:issn><owl:sameAs>urn:issn:1750-7448</owl:sameAs><j.0:title>Immunotherapy</j.0:title><j.1:issn>1750-743X</j.1:issn><j.2:issn>1750-743X</j.2:issn></j.2:Journal></j.0:isPartOf><j.1:volume>9</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/felix-y-feng-37wqyi2oky0ga"><j.3:name>Felix Y Feng</j.3:name><j.3:familyName>Feng</j.3:familyName><j.3:givenName>Felix Y</j.3:givenName></j.3:Person></j.0:creator><j.0:publisher>Future Medicine Ltd</j.0:publisher><j.2:volume>9</j.2:volume><j.0:title>Convergence of immunotherapy, radiotherapy and prostate cancer: challenges and opportunities</j.0:title><j.1:endingPage>699</j.1:endingPage><j.0:identifier>10.2217/imt-2017-0059</j.0:identifier></rdf:Description></rdf:RDF>
